Filed: 2/14/2025ACC: 0001104659-25-013432
📋 What this filing means
ACUTA CAPITAL PARTNERS, LLC filed this quarterly 13F‑HR report disclosing 39 equity positions with a total reported market value of $99.40M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
39
Positions
$99.40M
Total AUM (reported)
12.68M
Total Shares
Allocation by class
COM$69.51M69.9%
SPONSORED ADR$7.41M7.5%
COM PAR $.01$7.24M7.3%
COM NEW$5.99M6.0%
SPON ADS$2.73M2.7%
CL A ORD SHS$1.90M1.9%
COM SHS$1.53M1.5%
Portfolio Concentration
Top 3$23.86M24.0%
4–10$36.15M36.4%
11–25$30.82M31.0%
Rest$8.57M8.6%
Top 3 weight
24.0%
Top 10 weight
60.4%
Voting Authority Distribution
Total shares with voting rights: 12.68M
Sole
Full voting authority
12.68M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole39
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings39
Rows:
OCULAR THERAPEUTIX INC
SOLEShares1.11M
TypeSH
Market value$9.49M
9.55%
Sole
1.11M
Shared
0.00
None
0.00
INSMED INC
SOLEShares104.80K
TypeSH
Market value$7.24M
7.28%
Sole
104.80K
Shared
0.00
None
0.00
TOURMALINE BIO INC
SOLEShares351.84K
TypeSH
Market value$7.14M
7.18%
Sole
351.84K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares122.90K
TypeSH
Market value$6.28M
6.32%
Sole
122.90K
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares267.37K
TypeSH
Market value$6.02M
6.05%
Sole
267.37K
Shared
0.00
None
0.00
AADI BIOSCIENCES INC
SOLEShares1.85M
TypeSH
Market value$5.83M
5.87%
Sole
1.85M
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares67.50K
TypeSH
Market value$5.19M
5.23%
Sole
67.50K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares111.70K
TypeSH
Market value$4.89M
4.92%
Sole
111.70K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares6.91K
TypeSH
Market value$4.25M
4.28%
Sole
6.91K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares45K
TypeSH
Market value$3.68M
3.71%
Sole
45K
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares771.96K
TypeSH
Market value$3.18M
3.20%
Sole
771.96K
Shared
0.00
None
0.00
ASCENDIS PHA-ADR
SOLEShares22.98K
TypeSH
Market value$3.16M
3.18%
Sole
22.98K
Shared
0.00
None
0.00
MEREO BIOPHARMA GROUP PL-ADR
SOLEShares779.31K
TypeSH
Market value$2.73M
2.74%
Sole
779.31K
Shared
0.00
None
0.00
BRIGHT MINDS BIOSCIENCES INC
SOLEShares69.12K
TypeSH
Market value$2.49M
2.50%
Sole
69.12K
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares447.50K
TypeSH
Market value$2.48M
2.49%
Sole
447.50K
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares87.66K
TypeSH
Market value$2.34M
2.35%
Sole
87.66K
Shared
0.00
None
0.00
HELIX ACQUISITION CORP II
SOLEShares180.94K
TypeSH
Market value$1.90M
1.91%
Sole
180.94K
Shared
0.00
None
0.00
UNICYCIVE THERAPEUTICS INC
SOLEShares2.30M
TypeSH
Market value$1.83M
1.84%
Sole
2.30M
Shared
0.00
None
0.00
ROCKET PHARMACEUTICALS INC
SOLEShares134.50K
TypeSH
Market value$1.69M
1.70%
Sole
134.50K
Shared
0.00
None
0.00
LIQUIDIA CORPORATION
SOLEShares137.71K
TypeSH
Market value$1.62M
1.63%
Sole
137.71K
Shared
0.00
None
0.00
MERSANA THERAPEUTICS INC
SOLEShares1.12M
TypeSH
Market value$1.60M
1.61%
Sole
1.12M
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares884.24K
TypeSH
Market value$1.53M
1.54%
Sole
884.24K
Shared
0.00
None
0.00
TECTONIC THERAPEUTIC INC
SOLEShares33.01K
TypeSH
Market value$1.52M
1.53%
Sole
33.01K
Shared
0.00
None
0.00
CIDARA THERAPEUTICS INC
SOLEShares54.47K
TypeSH
Market value$1.46M
1.47%
Sole
54.47K
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA CO NV
SOLEShares50K
TypeSH
Market value$1.28M
1.29%
Sole
50K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
OCULAR THERAPEUTIX INCSOLE | COM | 1.11M | SH | $9.49M 9.55% | 1.11M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 104.80K | SH | $7.24M 7.28% | 104.80K | 0.00 | 0.00 |
TOURMALINE BIO INCSOLE | COM | 351.84K | SH | $7.14M 7.18% | 351.84K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 122.90K | SH | $6.28M 6.32% | 122.90K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 267.37K | SH | $6.02M 6.05% | 267.37K | 0.00 | 0.00 |
AADI BIOSCIENCES INCSOLE | COM | 1.85M | SH | $5.83M 5.87% | 1.85M | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM | 67.50K | SH | $5.19M 5.23% | 67.50K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 111.70K | SH | $4.89M 4.92% | 111.70K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 6.91K | SH | $4.25M 4.28% | 6.91K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 45K | SH | $3.68M 3.71% | 45K | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 771.96K | SH | $3.18M 3.20% | 771.96K | 0.00 | 0.00 |
ASCENDIS PHA-ADRSOLE | SPONSORED ADR | 22.98K | SH | $3.16M 3.18% | 22.98K | 0.00 | 0.00 |
MEREO BIOPHARMA GROUP PL-ADRSOLE | SPON ADS | 779.31K | SH | $2.73M 2.74% | 779.31K | 0.00 | 0.00 |
BRIGHT MINDS BIOSCIENCES INCSOLE | COM NEW | 69.12K | SH | $2.49M 2.50% | 69.12K | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 447.50K | SH | $2.48M 2.49% | 447.50K | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 87.66K | SH | $2.34M 2.35% | 87.66K | 0.00 | 0.00 |
HELIX ACQUISITION CORP IISOLE | CL A ORD SHS | 180.94K | SH | $1.90M 1.91% | 180.94K | 0.00 | 0.00 |
UNICYCIVE THERAPEUTICS INCSOLE | COM | 2.30M | SH | $1.83M 1.84% | 2.30M | 0.00 | 0.00 |
ROCKET PHARMACEUTICALS INCSOLE | COM | 134.50K | SH | $1.69M 1.70% | 134.50K | 0.00 | 0.00 |
LIQUIDIA CORPORATIONSOLE | COM NEW | 137.71K | SH | $1.62M 1.63% | 137.71K | 0.00 | 0.00 |
MERSANA THERAPEUTICS INCSOLE | COM | 1.12M | SH | $1.60M 1.61% | 1.12M | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | COM SHS | 884.24K | SH | $1.53M 1.54% | 884.24K | 0.00 | 0.00 |
TECTONIC THERAPEUTIC INCSOLE | COM | 33.01K | SH | $1.52M 1.53% | 33.01K | 0.00 | 0.00 |
CIDARA THERAPEUTICS INCSOLE | COM NEW | 54.47K | SH | $1.46M 1.47% | 54.47K | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA CO NVSOLE | ORDINARY SHARES | 50K | SH | $1.28M 1.29% | 50K | 0.00 | 0.00 |
Page 1 of 2